AlzChem Group AG
ALZCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $0 |
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | 2.5% | -0.3% | 28.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 65.1% | 55.3% | 52.1% | 63.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 19.4% | 15.1% | 12.9% | 14.8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 9.8% | 6.4% | 5.5% | 6.5% |
| EPS Diluted | 5.31 | 3.4 | 2.97 | 2.72 |
| % Growth | 56.2% | 14.5% | 9.2% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |